Abbott Laboratories Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 10 | $0.96 | $0.96 | $0.96 |
| Q2 2024 | 6 | $1.10 | $1.10 | $1.10 |
| Q3 2024 | 6 | $1.20 | $1.20 | $1.20 |
| Q4 2024 | 15 | $1.33 | $1.36 | $1.34 |
| Q1 2025 | 9 | $1.08 | $1.19 | $1.11 |
| Q2 2025 | 8 | $1.24 | $1.28 | $1.27 |
| Q3 2025 | 4 | $1.31 | $1.35 | $1.33 |
| Q4 2025 | 5 | $1.43 | $1.48 | $1.46 |
| Q1 2026 | 5 | $1.23 | $1.27 | $1.25 |
| Q2 2026 | 3 | $1.39 | $1.44 | $1.42 |
| Q3 2026 | 3 | $1.45 | $1.50 | $1.48 |
| Q4 2026 | 5 | $1.57 | $1.62 | $1.60 |
Abbott Laboratories Earnings Date And Information
Abbott Laboratories last posted its earnings results on Wednesday, October 16th, 2024. The company reported $1.21 earnings per share for the quarter, topping analysts' consensus estimates of $1.2 by $0.01. The company had revenue of 10.64 B for the quarter and had revenue of 40.11 B for the year. Abbott Laboratories has generated $3 earnings per share over the last year ($3.26 diluted earnings per share) and currently has a price-to-earnings ratio of 34.95. Abbott Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 21st, 2025 based on prior year's report dates.
Abbott Laboratories Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2024 | Q3 2024 | $0.94 | $10.55 B | $10.64 B | ||
| 07/31/2024 | Q2 2024 | $0.75 | $10.37 B | $10.38 B | ||
| 05/02/2024 | Q1 2024 | $0.71 | $9.96 B | |||
| 02/16/2024 | Q4 2023 | $0.92 | $10.24 B | |||
| 11/01/2023 | Q3 2023 | $0.83 | $9.84 B | $10.14 B | ||
| 08/03/2023 | Q2 2023 | $0.79 | $9.71 B | $9.98 B | ||
| 05/04/2023 | Q1 2023 | $0.76 | $9.75 B | |||
| 02/17/2023 | Q4 2022 | $0.59 | $10.09 B | |||
| 11/01/2022 | Q3 2022 | $0.82 | $9.65 B | $10.41 B | ||
| 08/02/2022 | Q2 2022 | $1.15 | $10.33 B | $11.26 B | ||
| 05/03/2022 | Q1 2022 | $1.40 | $11.90 B | |||
| 02/18/2022 | Q4 2021 | $1.13 | $11.47 B | |||
| 11/03/2021 | Q3 2021 | $1.19 | $9.56 B | $10.93 B | ||
| 08/04/2021 | Q2 2021 | $0.67 | $9.69 B | $10.22 B | ||
| 05/05/2021 | Q1 2021 | $1.01 | $10.46 B | |||
| 02/19/2021 | Q4 2020 | $1.22 | $10.70 B | |||
| 11/04/2020 | Q3 2020 | $0.70 | $8.54 B | $8.85 B | ||
| 07/29/2020 | Q2 2020 | $0.30 | $6.81 B | $7.33 B | ||
| 04/29/2020 | Q1 2020 | $0.32 | $7.73 B | |||
| 02/21/2020 | Q4 2019 | $0.60 | $8.31 B |
Abbott Laboratories Earnings: Frequently Asked Questions
-
When is Abbott Laboratories's earnings date?
Abbott Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 21st, 2025 based off last year's report dates.
-
Did Abbott Laboratories beat their earnings estimates last quarter?
In the previous quarter, Abbott Laboratories (:ABT) reported $1.21 earnings per share (EPS) to beat the analysts' consensus estimate of $1.2 by $0.01.
-
How can I listen to Abbott Laboratories's earnings conference call?
The conference call for Abbott Laboratories's latest earnings report can be listened to online.
-
How can I read Abbott Laboratories's conference call transcript?
The conference call transcript for Abbott Laboratories's latest earnings report can be read online.
-
How much revenue does Abbott Laboratories generate each year?
Abbott Laboratories (:ABT) has a recorded annual revenue of $40.11 B.
-
How much profit does Abbott Laboratories generate each year?
Abbott Laboratories (:ABT) has a recorded net income of $40.11 B. Abbott Laboratories has generated $3.3 earnings per share over the last four quarters.
-
What is Abbott Laboratories's price-to-earnings ratio?
Abbott Laboratories (:ABT) has a price-to-earnings ratio of 34.95 and price/earnings-to-growth ratio is 10.2.
